The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and D…
- Recall date
- March 24, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0485-2026
- FDA classification
- Class II
- Brand / firm
- The Harvard Drug Group LLC
- Sold / distributed
- US Nationwide.
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
Get recall alerts
Free email alert whenever The Harvard Drug Group LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: The Harvard Drug Group LLC